Latest filing published 14 Jun 2023 for Talaris Therapeutics, Inc., €41k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Suzanne Ildstad on record concern Talaris Therapeutics, Inc., in the capacity of senior executive. Over a trading history stretching from 17 November 2021 to 12 June 2023, the count stands at 19 filings.
On the market, this insider has only sold: 18 sales, €2.1M in total. In 2023 alone, the filings show no purchases and 17 sales.
The record was last updated on 14 June 2023 with an open-market sale (€41k) in Talaris Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations